⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17231360 | 1.00 | — | — | |
| SCHEMBL20112968 | 0.96 | — | — | |
| SCHEMBL18231243 | 0.82 | — | — | |
| SCHEMBL18429987 | 0.82 | — | — | |
| SCHEMBL20115465 | 0.79 | — | — | |
| SCHEMBL20404505 | 0.78 | — | — | |
| SCHEMBL24348513 | 0.77 | — | — | |
| SCHEMBL21147433 | 0.77 | — | — | |
| SCHEMBL8524886 | 0.77 | — | — | |
| SCHEMBL18231811 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10292972-B1 | Pharmaceutical composition for treating cancer and a method thereof | KING ABDULAZIZ UNIVERSITY (SA) | 2019-05-21 | — | — | US | disclosed |
| US-20190125732-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND A METHOD THEREOF | KING ABDULAZIZ UNIVERSITY (SA) | 2019-05-02 | — | — | US | disclosed |
| US-20180030207-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2018-02-01 | — | — | US | disclosed |
| US-20160149005-A1 | SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD FOR SAME, CRYSTAL, AND MANUFACTURING METHOD FOR SAME | FLOSFIA INC. (JP) | 2016-05-26 | — | — | US | disclosed |
| EP-2692826-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2016-04-13 | — | — | EP | disclosed |
| EP-2692827-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2016-03-23 | — | — | EP | disclosed |
| US-9249163-B2 | PDE10a inhibitors for the treatment of type II diabetes | JANSSEN PHARMACEUTICA NV. (BE) | 2016-02-02 | — | — | US | disclosed |
| US-20150203634-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2015-07-23 | — | — | US | disclosed |
| US-20150062112-A1 | Electronic Circuit, Display Device, Electronic Device, And Method For Driving Electronic Circuit | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-05 | — | — | US | disclosed |
| US-20140364414-A1 | PDE 10a Inhibitors for the Treatment of Type II Diabetes | JANSSEN PHARMACEUTICA, NV (BE) | 2014-12-11 | — | — | US | disclosed |
| EP-2206736-A1 | Polyglutamate-amino acid conjugates and methods | Nitto Denko Corporation (JP) | 2010-07-14 | — | — | EP | disclosed |
| US-20090297558-A1 | Inactivated Influenza Virus Compositions | DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH, GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2009-12-03 | — | — | US | disclosed |
| US-20090269325-A1 | Methods for treating bleeding disorders using sulfated polysaccharides | BAXTER INTERNATIONAL INC. (US) | 2009-10-29 | — | — | US | disclosed |
| US-20090238763-A1 | HIGH PENETRATION COMPOSITIONS AND USES THEREOF | TECHFIELDS PHARMA CO., LTD. (CN) | 2009-09-24 | — | — | US | disclosed |
| EP-2077290-A1 | Polyglutamate-amino acid conjugates and methods | Nitto Denko Corporation (JP) | 2009-07-08 | — | — | EP | disclosed |
| EP-1969031-B1 | POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | NITTO DENKO CORP (JP) | 2009-06-03 | — | — | EP | disclosed |
| US-20090076251-A1 | FcGammaRIIB Specific Antibodies and Methods of Use Thereof | MACROGENICS, INC. (US) | 2009-03-19 | — | — | US | disclosed |
| US-20090036468-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECEPTOR LIGANDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-02-05 | — | — | US | disclosed |
| US-20090011464-A1 | Humanized immunoglubulin reactive with alph4beta7 integrin | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-01-08 | — | — | US | disclosed |
| US-20080079064-A1 | Semiconductor device and method of manufacturing the same | MACRONIX INTERNATIONAL CO., LTD. (TW) | 2008-04-03 | — | — | US | disclosed |